RxDoctor Payments DataLook up a doctor →

Alaa Abd-Elsayed

Pain Medicine · Madison, WINPI 1194967703

Payments from drug & device makers

$1,972,286in general payments, 2019–2025

Across 1,193 payments — averaging $1653.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$723K
  • Curonix LLC$371K
  • GRT US Holding, Inc.$252K
  • Stimwave Technologies Incorporated$180K
  • Averitas Pharma Inc.$154K
  • Avanos Medical$143K
  • plus $149K from 20 others
$66,462in research payments, 2019–2025

Across 9 payments — averaging $7384.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stimwave Technologies Incorporated$26K
  • Medtronic$24K
  • Painteq LLC$16K

What the payments were for

  • Consulting fees$659,87450%
  • Speaking & faculty fees$434,70133%
  • Travel & lodging$182,80714%
  • Food & beverage$34,2353%
  • Education$1840%
  • Entertainment$840%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,972,286 in reported general payments places this provider in the 95th percentile of 82 pain medicine providers in Wisconsin.

See all pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$82,079
Medicare patients
298
Services billed
799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl16$52

Paid to pharmacies, not to this prescriber.

Other pain medicine in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →